什么时候,为什么,以及如何在肌心炎后的精神分裂症中重新挑战克洛扎
Mishal Qubad1, Gabriele Dupont2, Martina Hahn2,3
1Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University Frankfurt, University Hospital, Frankfurt, Germany. mishal.qubad@med.uni-frankfurt.de.
CNS drugs
|July 1, 2024
概括
克洛扎诱导心肌炎 (CIM) 可以通过仔细重新挑战患者使用克洛扎来管理. 本综述概述了心肌炎后安全使用克洛扎的策略,改善精神分裂症治疗结果.
科学领域:
- 精神病学是一个精神病学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 克洛扎平是一种至关重要的精神分裂症治疗方法,但克洛扎平诱导的心肌炎 (CIM) 往往导致永久停药.
- CIM显著恶化了患者的精神病理和长期结果.
- 在CIM后重新挑战克洛扎是一种可行的,尽管报告不足的替代方案,成功率为~60%.
研究的目的:
- 审查CIM的流行病学,病理生理学,危险因素,诊断和管理.
- 综合当前关于在CIM后重新挑战克洛沙平的建议.
- 为了提供一个步骤指南,安全的克洛沙平重新挑战后CIM.
主要方法:
- 对CIM和克洛扎再挑战现有研究的叙述性审查.
- 对CIM病理生理学和风险因素的现有证据的综合.
- 基于收集的证据,制定一个重新挑战的协议.
主要成果:
- 确定了CIM的关键风险因素,包括同时使用氨酸和奥兰扎.
- 强调缓慢剂量定位对于预防和安全重新挑战的重要性.
- 讨论了生物标志物 (CRP,热素,NT-proBNP) 和心脏MRI的诊断和查实用程序.
结论:
- 在CIM后,对选择的患者来说,重新挑战克洛沙平是可行的和有益的.
- 精心管理,包括缓慢定位和降低风险因素,对于成功重新挑战至关重要.
- 生物标志物和心脏成像帮助CIM查,诊断和再挑战后监测.
更多相关视频
相关概念视频
01:24Mania and Antimanic Drugs: Overview
163
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
163
01:27Psychoneuroimmunology: Cardiovascular Disease
30
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
30
01:17Schizophrenia
74
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
74
01:23Antidepressant Drugs: MAOIs and Other Agents
215
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
215